Want to learn more?
We help you understand how market dynamics, clinical innovations, and competitive threats affect the future potential for your products, so you can prioritise your pipeline and align your portfolio with your business strategy.
Deep knowledge of market characteristics and dynamics
Anticipate and manage challenges around your target market, thanks to our vast experience in oncology and rare diseases.
Collaboration, expertise and efficiency
Make confident decisions, with help from our clinical, epidemiology, access and forecasting experts.
Robust and comprehensive data sources
We will apply data from the most appropriate of a broad range of sources, to best meet your requirements.
- Assessing pipeline composition and gap analysis
- Appraising the landscape, competitive market and market access
- Evaluating product clinical utility and commercial value
- Forecasting revenues, and valuing assets
We have over 25 years of experience in oncology. Our teams are made up of over 100 oncology specialists, many with advanced degrees and commercial pharma experience. Their collective experience bring a holistic perspective to your engagement that is unbiased and rooted in local and global data.
We support our engagements with accurate and reliable data from a range of sources, including CancerMPact®, CancerLandscape®, and Epi Database®.
We use a holistic approach, integrating the appropriate experts and data to meet your requirements.